A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Immune Thrombocytopenia
Related studies linked through entity extraction aliases.
ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
- Status
- COMPLETED
- Phase
- N/A
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Eltrombopag at Escalated Doses
- Status
- COMPLETED
- Phase
- PHASE2
The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
- Status
- WITHDRAWN
- Phase
- N/A
Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment
- Status
- WITHDRAWN
- Phase
- N/A
Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP
- Status
- UNKNOWN
- Phase
- PHASE3
Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
- Status
- COMPLETED
- Phase
- N/A
Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.
- Status
- COMPLETED
- Phase
- N/A
A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE2
Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
- Status
- COMPLETED
- Phase
- PHASE3
End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
- Status
- TERMINATED
- Phase
- N/A
An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)
- Status
- TERMINATED
- Phase
- PHASE2
Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
- Status
- COMPLETED
- Phase
- PHASE2